Latest United States Startup Funding Rounds
Startup funding in United States: recent rounds, the companies behind them and their participating investors.
- Rounds
- 772 Jul 12 – Oct 9, 2026
- Disclosed funding
- $67.1B 615 disclosed amounts
- Median round
- $22.5M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| KT Khartis TherapeuticsCompany profile Develops oral small molecule therapies for immunological and chronic diseases Develops oral small molecule therapies for immunological and chronic diseases | $50M | Series B | Biotech | United States | Investors | |
| HI Heaviside IndustriesCompany profile Builds autonomous precision munitions platforms for air, land, and sea forces Builds autonomous precision munitions platforms for air, land, and sea forces | $60M | Series B | Defense tech | United States | Investors | |
| EF Provides technology and capital access for consumer credit lending markets | Undisclosed | Growth | Fintech | United States | Investors | |
| R ReservoirCompany profile Reservoir makes and installs predictive all-electric water heaters designed to serve homeowners and respond to energy needs. Reservoir makes and installs predictive all-electric water heaters designed to serve homeowners and respond to energy needs. | $8M | Seed | Climate tech | United States | Investors | |
| AH Amplifica Holdings GroupCompany profile Amplifica develops injectable drug candidates intended to reactivate hair follicles in people with androgenetic alopecia. Amplifica develops injectable drug candidates intended to reactivate hair follicles in people with androgenetic alopecia. | $26M | Series B | Biotech | United States | Investors | |
| I InduProCompany profile Develops proximity-guided antibody-drug conjugate therapeutics for cancer and autoimmune disease Develops proximity-guided antibody-drug conjugate therapeutics for cancer and autoimmune disease | $77M | Series B | Biotech | United States | Investors | |
| DP Digital Prime TechnologiesCompany profile Provides institutional technology for digital asset and tokenized asset lending Provides institutional technology for digital asset and tokenized asset lending | Undisclosed | StrategicUndisclosed | Fintech | United States | Investors | |
| C ClearJetCompany profile Connects shippers to unused commercial flight cargo space for faster package delivery Connects shippers to unused commercial flight cargo space for faster package delivery | $25M | Growth | Logistics | United States | Investors | |
| Bt Bridge to LifeCompany profile Makes organ preservation and perfusion technology for liver transplants Makes organ preservation and perfusion technology for liver transplants | $110M | Series C+DebtUndisclosed | Healthtech | United States | Investors | |
| B BlacksmithCompany profile Cloud infrastructure for building and testing software through continuous integration workflows. Cloud infrastructure for building and testing software through continuous integration workflows. | $45M | Series B | Developer tools | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jul 12, 2026
- 1Y Combinator (YC)
Nous Research, Santé, Vitalize
55rounds3led - 2Andreessen Horowitz (a16z)
TypeSafe AI, Arena, Vesta
40rounds15led - 3Khosla Ventures
Arena, Vinci, Conway Research
25rounds5led - 4Sequoia Capital
TypeSafe AI, Mecka, Healthleap
23rounds5led - 5Insight Partners
Stuut, Hestus, Inc., Quartermaster
21rounds9led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.